What is the price-to-earnings ratio of Athersys?
The price-earnings ratio of Athersys is currently 0.
Athersys P/S 2024
Athersys P/S
0
Ticker
ATHX
ISIN
US04744L1061
WKN
A0M085
As of Nov 1, 2024, Athersys's P/S ratio stood at 0, a 0% change from the 0 P/S ratio recorded in the previous year.
The Athersys P/S history
Athersys Aktienanalyse
What does Athersys do?
Athersys Inc. is a biopharmaceutical company based in Cleveland, Ohio. It was founded in 1995 and focuses on the discovery, development, and commercialization of regenerative therapies and cell therapies. The idea for founding Athersys Inc. came from the vision that stem cell therapies could change the way we treat diseases. In the early stages of the company, the team focused on isolating and characterizing human stem cells. Over time, the research evolved and Athersys Inc. shifted its focus to developing drugs that promote tissue and organ regeneration. Athersys Inc.'s business model involves developing stem cell-based medications that are tested in clinical trials. The goal is to combat diseases such as stroke, heart attack, inflammatory diseases, and respiratory syndromes. Athersys Inc. utilizes a proprietary technology platform called MultiStem to isolate, expand, and differentiate stem cells. The company works closely with clinical partners in the pharmaceutical and biotech industry to conduct clinical trials and bring medications to market. Athersys has four divisions: Hematology, Neurology, Pulmonology, and Cardiology. In hematology, Athersys focuses on developing a therapy for cancer treatment. By administering MultiStem, a type of stem cell therapy, they hope to reduce the side effects of chemotherapy and kill cancer cells. In neurology, Athersys focuses on developing medications for the treatment of strokes and neurological disorders. The goal is to trigger regenerative processes in the brain and promote the growth of nerve cells and the regeneration of brain tissue. In pulmonology, Athersys focuses on developing therapies for the treatment of lung diseases such as ARDS and COPD. In cardiology, Athersys aims to improve the healing process after a heart attack by supporting the natural regeneration process of the heart muscle. Athersys' products are still in development and are in various stages of clinical trials. The most well-known product of Athersys is the MultiStem product. The company utilizes its proprietary technology platform to isolate and expand stem cells from human bone marrow and adipose tissue. MultiStem is intended to promote tissue regeneration and reduce inflammation. It has been tested in various preclinical and clinical trials and has shown promising results. Overall, Athersys Inc. is a company that focuses on regenerative therapies and cell therapies. By utilizing its proprietary technology platform MultiStem, Athersys hopes to develop stem cell-based therapies that can contribute to the cure of many different diseases. Although the company is still in the development and study phase, Athersys has already made impressive progress and remains an important player in the biopharmaceutical industry. Athersys ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Athersys's P/S Ratio
Athersys's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Athersys's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Athersys's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Athersys’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Athersys stock
How has the price-earnings ratio of Athersys changed compared to last year?
The price-to-earnings ratio of Athersys has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Athersys high compared to other companies?
Yes, the price-to-earnings ratio of Athersys is high compared to other companies.
How does an increase in the price-earnings ratio of Athersys affect the company?
An increase in the price-earnings ratio of Athersys would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Athersys affect the company?
A decrease in the price-earnings ratio of Athersys would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Athersys?
Some factors that influence the price-earnings ratio of Athersys are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Athersys pay?
Over the past 12 months, Athersys paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Athersys is expected to pay a dividend of 0 USD.
What is the dividend yield of Athersys?
The current dividend yield of Athersys is .
When does Athersys pay dividends?
Athersys pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Athersys?
Athersys paid dividends every year for the past 0 years.
What is the dividend of Athersys?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Athersys located?
Athersys is assigned to the 'Health' sector.
Wann musste ich die Aktien von Athersys kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Athersys from 11/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/1/2024.
When did Athersys pay the last dividend?
The last dividend was paid out on 11/1/2024.
What was the dividend of Athersys in the year 2023?
In the year 2023, Athersys distributed 0 USD as dividends.
In which currency does Athersys pay out the dividend?
The dividends of Athersys are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Athersys
Our stock analysis for Athersys Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Athersys Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
